Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
  • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
  • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
  • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
  • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
  • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/10—Antimycotics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
  • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
  • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
  • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
• • G—PHYSICS
  • G06—COMPUTING OR CALCULATING; COUNTING
  • G06F—ELECTRIC DIGITAL DATA PROCESSING
  • G06F1/00—Details not covered by groups G06F3/00 - G06F13/00 and G06F21/00
  • G06F1/26—Power supply means, e.g. regulation thereof
  • G06F1/32—Means for saving power
  • G06F1/3203—Power management, i.e. event-based initiation of a power-saving mode
  • G06F1/3234—Power saving characterised by the action undertaken
  • G06F1/325—Power saving in peripheral device
  • G06F1/3268—Power saving in hard disk drive
• • G—PHYSICS
  • G11—INFORMATION STORAGE
  • G11C—STATIC STORES
  • G11C11/00—Digital stores characterised by the use of particular electric or magnetic storage elements; Storage elements therefor
  • G11C11/21—Digital stores characterised by the use of particular electric or magnetic storage elements; Storage elements therefor using electric elements
  • G11C11/34—Digital stores characterised by the use of particular electric or magnetic storage elements; Storage elements therefor using electric elements using semiconductor devices
  • G11C11/40—Digital stores characterised by the use of particular electric or magnetic storage elements; Storage elements therefor using electric elements using semiconductor devices using transistors
  • G11C11/401—Digital stores characterised by the use of particular electric or magnetic storage elements; Storage elements therefor using electric elements using semiconductor devices using transistors forming cells needing refreshing or charge regeneration, i.e. dynamic cells
  • G11C11/4063—Auxiliary circuits, e.g. for addressing, decoding, driving, writing, sensing or timing
  • G11C11/407—Auxiliary circuits, e.g. for addressing, decoding, driving, writing, sensing or timing for memory cells of the field-effect type
  • G11C11/4074—Power supply or voltage generation circuits, e.g. bias voltage generators, substrate voltage generators, back-up power, power control circuits

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Medicinal Chemistry (AREA)
• Public Health (AREA)
• Pharmacology & Pharmacy (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Epidemiology (AREA)
• Engineering & Computer Science (AREA)
• Theoretical Computer Science (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Microelectronics & Electronic Packaging (AREA)
• Physics & Mathematics (AREA)
• General Engineering & Computer Science (AREA)
• General Physics & Mathematics (AREA)
• Computer Hardware Design (AREA)
• Oncology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Communicable Diseases (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Plural Heterocyclic Compounds (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=52006914

Family Applications (1)

Country Status (18)

Families Citing this family (10)

Family Cites Families (20)

• 2015
  • 2015-12-04 BR BR112017008481-3A patent/BR112017008481B1/pt active IP Right Grant
  • 2015-12-04 WO PCT/GB2015/053733 patent/WO2016087880A1/en not_active Ceased
  • 2015-12-04 JP JP2017528775A patent/JP6669751B2/ja active Active
  • 2015-12-04 CN CN202011308132.2A patent/CN112375073B/zh active Active
  • 2015-12-04 PT PT158087700T patent/PT3227277T/pt unknown
  • 2015-12-04 SG SG11201702835RA patent/SG11201702835RA/en unknown
  • 2015-12-04 WO PCT/GB2015/053731 patent/WO2016087878A1/en not_active Ceased
  • 2015-12-04 EA EA201791174A patent/EA033736B1/ru not_active IP Right Cessation
  • 2015-12-04 MX MX2017007188A patent/MX370412B/es active IP Right Grant
  • 2015-12-04 EP EP15817507.5A patent/EP3227278B1/en active Active
  • 2015-12-04 EP EP15808770.0A patent/EP3227277B1/en active Active
  • 2015-12-04 AU AU2015356795A patent/AU2015356795B2/en active Active
  • 2015-12-04 KR KR1020177013730A patent/KR102579848B1/ko active Active
  • 2015-12-04 CN CN201580066092.6A patent/CN107001343B/zh active Active
  • 2015-12-04 CA CA2963625A patent/CA2963625C/en active Active
  • 2015-12-04 HU HUE15808770A patent/HUE048905T2/hu unknown
  • 2015-12-04 US US15/524,505 patent/US10106531B2/en active Active
  • 2015-12-04 DK DK15808770.0T patent/DK3227277T3/da active
  • 2015-12-04 ES ES15817507T patent/ES2786374T3/es active Active
  • 2015-12-04 PL PL15808770T patent/PL3227277T3/pl unknown
  • 2015-12-04 ES ES15808770T patent/ES2790875T3/es active Active
  • 2015-12-04 DK DK15817507.5T patent/DK3227278T3/da active
  • 2015-12-04 JP JP2017528789A patent/JP6666345B2/ja active Active
  • 2015-12-04 HU HUE15817507A patent/HUE048685T2/hu unknown
• 2016
  • 2016-10-20 US US15/298,431 patent/US10093659B2/en active Active
• 2017
  • 2017-04-06 IL IL251631A patent/IL251631B/en active IP Right Grant
• 2018
  • 2018-09-12 US US16/129,322 patent/US10487073B2/en active Active
  • 2018-09-24 US US16/139,591 patent/US10344022B2/en active Active
• 2019
  • 2019-05-24 US US16/422,062 patent/US10450304B2/en active Active
  • 2019-09-12 US US16/569,128 patent/US10662179B2/en active Active
  • 2019-10-04 US US16/593,444 patent/US10800762B2/en active Active
• 2020
  • 2020-04-15 US US16/849,476 patent/US10858345B2/en active Active
  • 2020-09-04 US US17/012,685 patent/US11008307B2/en active Active
  • 2020-11-04 US US17/089,441 patent/US11661415B2/en active Active
• 2021
  • 2021-04-14 US US17/230,009 patent/US20210238169A1/en not_active Abandoned
• 2023
  • 2023-04-18 US US18/302,557 patent/US12269814B2/en active Active

Also Published As

Similar Documents